Unaudited Results for the quarter ended 30.06.2025
TRANSPEK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transpek Industry's Board of Directors, at its meeting on 5 August 2025, approved the unaudited standalone and consolidated financial results for the quarter ended 30 June 2025, which had been earlier reviewed by the Audit Committee. Revenue from operations stood at Rs 15,423.32 lakhs (standalone) versus Rs 15,186.07 lakhs in Q1 FY25, broadly flat at about 1.6% growth. However, profit after tax surged dramatically to Rs 1,558.11 lakhs from Rs 237.35 lakhs in the year-ago quarter, a jump of over 550%, indicating strong margin expansion. Total comprehensive income for the quarter was Rs 1,935.70 lakhs. The auditor Bansi S. Mehta & Co. issued an unqualified review report on both standalone and consolidated results, confirming no material misstatements. The trading window closed from 1 July 2025 will re-open on 8 August 2025.
Sharp PAT growth against flat revenue signals significant margin improvement for shareholders. A clean auditor review with no qualifications reinforces confidence in the reported numbers, which is broadly positive for the stock.